The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Alendronic Acid Once Weekly 70 mg Tablets

70 milligram(s) Tablet

Accord Healthcare Ireland Ltd.PA2315/032/001

Main Information

Trade NameAlendronic Acid Once Weekly 70 mg Tablets
Active SubstancesAlendronic acid
Strength70 milligram(s)
Dosage FormTablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/032/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA04 alendronic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued18/02/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThe product shall not be marketed in Ireland until a variation to update the product information (SPC, package leaflet and labelling) is approved, in accordance with written commitment of the MAH, dated 30. 10. 2010.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0051-101-002
Interchangeable List DocumentPDF of Interchangeable List
« Back